1. Home
  2. OVID vs FEAM Comparison

OVID vs FEAM Comparison

Compare OVID & FEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • FEAM
  • Stock Information
  • Founded
  • OVID 2014
  • FEAM 2016
  • Country
  • OVID United States
  • FEAM United States
  • Employees
  • OVID N/A
  • FEAM N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • FEAM Major Chemicals
  • Sector
  • OVID Health Care
  • FEAM Industrials
  • Exchange
  • OVID Nasdaq
  • FEAM Nasdaq
  • Market Cap
  • OVID 88.9M
  • FEAM 78.3M
  • IPO Year
  • OVID 2017
  • FEAM N/A
  • Fundamental
  • Price
  • OVID $1.48
  • FEAM $6.44
  • Analyst Decision
  • OVID Strong Buy
  • FEAM Strong Buy
  • Analyst Count
  • OVID 4
  • FEAM 2
  • Target Price
  • OVID $3.13
  • FEAM $8.25
  • AVG Volume (30 Days)
  • OVID 5.7M
  • FEAM 330.7K
  • Earning Date
  • OVID 11-11-2025
  • FEAM 11-12-2025
  • Dividend Yield
  • OVID N/A
  • FEAM N/A
  • EPS Growth
  • OVID N/A
  • FEAM N/A
  • EPS
  • OVID N/A
  • FEAM N/A
  • Revenue
  • OVID $6,651,000.00
  • FEAM N/A
  • Revenue This Year
  • OVID $1,086.57
  • FEAM N/A
  • Revenue Next Year
  • OVID N/A
  • FEAM $500.00
  • P/E Ratio
  • OVID N/A
  • FEAM N/A
  • Revenue Growth
  • OVID 1070.95
  • FEAM N/A
  • 52 Week Low
  • OVID $0.24
  • FEAM $2.82
  • 52 Week High
  • OVID $2.01
  • FEAM $24.84
  • Technical
  • Relative Strength Index (RSI)
  • OVID 50.82
  • FEAM 66.41
  • Support Level
  • OVID $1.53
  • FEAM $4.66
  • Resistance Level
  • OVID $1.79
  • FEAM $7.46
  • Average True Range (ATR)
  • OVID 0.18
  • FEAM 0.92
  • MACD
  • OVID -0.03
  • FEAM 0.22
  • Stochastic Oscillator
  • OVID 34.42
  • FEAM 72.08

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

About FEAM 5E Advanced Materials Inc.

5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.

Share on Social Networks: